Selected article for: "additional file and immune response"

Author: Tchitchek, Nicolas; Eisfeld, Amie J; Tisoncik-Go, Jennifer; Josset, Laurence; Gralinski, Lisa E; Bécavin, Christophe; Tilton, Susan C; Webb-Robertson, Bobbie-Jo; Ferris, Martin T; Totura, Allison L; Li, Chengjun; Neumann, Gabriele; Metz, Thomas O; Smith, Richard D; Waters, Katrina M; Baric, Ralph; Kawaoka, Yoshihiro; Katze, Michael G
Title: Specific mutations in H5N1 mainly impact the magnitude and velocity of the host response in mice
  • Document date: 2013_7_29
  • ID: 1qc72ovc_29
    Snippet: Finally, the MC and VC profiles associated with VN1203-NS1trunc mutation largely changed at early dpi (1 and 2 dpi). At 1 dpi, these 2 coefficients were higher in the mutant than in the matched dose of the WT, but lower at 2 dpi (Figures 4, and 5D ). This was related to the enhanced, early expression (i.e. at 1 dpi, relative to 2 dpi for all other viruses) of transcripts directly involved in the innate immune response and inflammation (Additional.....
    Document: Finally, the MC and VC profiles associated with VN1203-NS1trunc mutation largely changed at early dpi (1 and 2 dpi). At 1 dpi, these 2 coefficients were higher in the mutant than in the matched dose of the WT, but lower at 2 dpi (Figures 4, and 5D ). This was related to the enhanced, early expression (i.e. at 1 dpi, relative to 2 dpi for all other viruses) of transcripts directly involved in the innate immune response and inflammation (Additional file 6: Figure S3 ), which was also reported previously [31] . It was interesting to find that this behavior was very similar to the CA04 at the highest dose (10 6 PFU). CA04-WT was used as a much lower pathogenicity comparator which confirmed that the main effect of increasing infection dose was to increase the magnitude of the hostresponse (Additional file 7: Figure S4 , and Figure 4 ).

    Search related documents:
    Co phrase search for related documents
    • additional file and early expression: 1
    • additional file and high dose: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • additional file and immune response: 1, 2, 3, 4, 5, 6, 7, 8
    • additional file and infection dose: 1
    • additional file and innate immune response: 1, 2, 3, 4
    • additional file and main effect: 1
    • early dpi and immune response: 1, 2, 3, 4, 5, 6
    • early dpi and innate immune response: 1, 2, 3, 4
    • early expression and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • early expression and infection dose: 1, 2
    • early expression and innate immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • early expression and previously report: 1, 2
    • high dose and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and increase infection dose: 1
    • high dose and infection dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and innate immune response: 1, 2, 3, 4
    • high dose and matched dose: 1, 2
    • high dose and previously report: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • immune response and previously report: 1, 2, 3, 4, 5, 6